
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
P3 Health Partners Inc (PIII)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: PIII (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $8
1 Year Target Price $8
2 | Strong Buy |
0 | Buy |
2 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 199.63% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.29B USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) 4 | Beta 0.83 | 52 Weeks Range 6.00 - 32.54 | Updated Date 06/29/2025 |
52 Weeks Range 6.00 - 32.54 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -52.42 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.27% | Operating Margin (TTM) -10.21% |
Management Effectiveness
Return on Assets (TTM) -23.86% | Return on Equity (TTM) -120.44% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 163633752 | Price to Sales(TTM) 0.87 |
Enterprise Value 163633752 | Price to Sales(TTM) 0.87 | ||
Enterprise Value to Revenue 0.11 | Enterprise Value to EBITDA -1.86 | Shares Outstanding 3268090 | Shares Floating 1199586 |
Shares Outstanding 3268090 | Shares Floating 1199586 | ||
Percent Insiders 61.95 | Percent Institutions 11.57 |
Analyst Ratings
Rating 2 | Target Price 8 | Buy - | Strong Buy 2 |
Buy - | Strong Buy 2 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
P3 Health Partners Inc
Company Overview
History and Background
P3 Health Partners Inc. was founded in 2017. It focuses on population health management and value-based care, primarily serving Medicare Advantage patients. The company aims to improve health outcomes and reduce healthcare costs.
Core Business Areas
- Medicare Advantage: P3 Health Partners provides care management and coordination services to Medicare Advantage members, working with independent physician associations (IPAs) and medical groups.
- Value-Based Care: P3 Health Partners operates under a value-based care model, where providers are incentivized to deliver high-quality, cost-effective care.
- Clinic Operations: Owns and operates medical clinics in several key geographies. They deliver primary care and chronic care services, focusing on underserved populations.
Leadership and Structure
Dr. Sherif Abdou is the current CEO. The organizational structure consists of operational teams responsible for care delivery, technology, and administrative support.
Top Products and Market Share
Key Offerings
- Care Management Programs: Care management programs for chronic conditions such as diabetes, heart disease, and chronic obstructive pulmonary disease (COPD). No specific market share data is available. Competitors: Optum, Oak Street Health.
- Risk Adjustment Services: Risk adjustment services to optimize reimbursement from Medicare Advantage plans. No specific market share data is available. Competitors: Inovalon, Cotiviti.
Market Dynamics
Industry Overview
The healthcare industry is shifting towards value-based care models. Medicare Advantage is experiencing significant growth, driven by an aging population and increasing demand for coordinated care.
Positioning
P3 Health Partners aims to be a leading provider of value-based care in the Medicare Advantage market. Its competitive advantages include its focus on population health management and its relationships with independent physician associations.
Total Addressable Market (TAM)
The Medicare Advantage market is expected to exceed $500 billion. P3 Health Partners is positioned to capture a portion of this market by expanding its geographic footprint and enhancing its care management capabilities.
Upturn SWOT Analysis
Strengths
- Focus on value-based care
- Experienced management team
- Strong relationships with IPAs
- Proprietary technology platform
Weaknesses
- Limited geographic presence
- Reliance on Medicare Advantage reimbursement
- History of net losses and negative cash flow
Opportunities
- Expansion into new geographic markets
- Increased penetration of existing markets
- Partnerships with other healthcare providers
- Adoption of new technologies
Threats
- Changes in Medicare Advantage reimbursement policies
- Increased competition from other value-based care providers
- Regulatory scrutiny
- Difficulty attracting and retaining physicians
Competitors and Market Share
Key Competitors
- UNH
- HUM
- CVS
Competitive Landscape
P3 Health Partners faces intense competition from larger, more established healthcare companies. Its competitive advantages include its focus on value-based care and its relationships with IPAs, but it is disadvantaged by its limited geographic presence and financial constraints.
Growth Trajectory and Initiatives
Historical Growth: P3 Health Partners has historically focused on expanding its geographic footprint and increasing the number of patients under management. However, due to market conditions, it experienced financial difficulties.
Future Projections: Future projections require real-time access to analyst estimates, which are not available.
Recent Initiatives: Recent initiatives included cost-cutting measures, restructuring efforts, and attempts to improve operational efficiency.
Summary
P3 Health Partners is a small player in the competitive healthcare landscape, focusing on value-based care within the Medicare Advantage program. While it has potential for growth, its financial performance and competitive disadvantages pose significant challenges. The company needs to address its profitability and expand its market presence to remain competitive. P3 Health Partners financial situation warrants careful consideration before investment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Market Analysis
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Financial data may be delayed or incomplete.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About P3 Health Partners Inc
Exchange NASDAQ | Headquaters Henderson, NV, United States | ||
IPO Launch date 2021-04-06 | CEO & President Dr. Aric Coffman M.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 360 | Website https://p3hp.org |
Full time employees 360 | Website https://p3hp.org |
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.